145720.KS
Dentium CO., LTD [145720.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
145720.KS Stock Summary
Top 145720.KS Correlated Resources
145720.KS
Top 10 Correlated ETFs
145720.KS
Top 10 Correlated Stocks
145720.KS
145720.KS Financial details
Company Rating
Buy
Market Cap
766.66B
Income
94.88B
Revenue
355.92B
Book val./share
44001.68
Cash/share
-
Dividend
250
Dividend %
0.28%
Employees
672
Optionable
No
Shortable
Yes
Earnings
15 Nov 2022
P/E
8.08
Forward P/E
-
PEG
0.44
P/S
2.15
P/B
2.02
P/C
-
P/FCF
17.77
Quick Ratio
-
Current Ratio
1.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
7.46K
EPS next Y
-
EPS next Q
-
EPS this Y
-79.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-32.18%
Revenue last 5Y
14.12%
Revenue Q/Q
-6.22%
EPS Q/Q
-32.12%
-
-
-
-
SMA20
11.86%
SMA50
-10.91%
SMA100
-0.71%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
29%
ROC
0.25%
Gross Margin
69%
Oper. Margin
33%
Profit Margin
27%
Payout
2%
Shs Outstand
8.62M
Shs Float
6.51M
-
-
-
-
Target Price
-
52W Range
52700.0-107000.0
52W High
-16.92%
52W Low
+68.69%
RSI
64
Rel Volume
0.75
Avg Volume
86.01K
Volume
64.81K
Perf Week
10.99%
Perf Month
11.54%
Perf Quarter
13.1%
Perf Half Y
15.3%
-
-
-
-
Beta
0.885714
-
-
Volatility
3236.84%, 4500.52%
Prev Close
0.68%
Price
88900
Change
0.11%
145720.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 18.47K | 21.6K | 29.29K | 26.64K | 2.78K | |
| Net income per share | 3.69K | 3.97K | 1.71K | 2.61K | 528.93 | |
| Operating cash flow per share | 2.66K | -66.63 | -1.35K | 8.78K | 706.51 | |
| Free cash flow per share | -6.3K | -12.69K | -7.43K | 7.73K | 429.64 | |
| Cash per share | 6.79K | 2.72K | 3.34K | 4.34K | 627.66 | |
| Book value per share | 19.84K | 22.51K | 24K | 26.59K | 2.78K | |
| Tangible book value per share | 19.7K | 22.3K | 23.68K | 26.26K | 2.75K | |
| Share holders equity per share | 19.84K | 22.51K | 24K | 26.59K | 2.78K | |
| Interest debt per share | 11.99K | 22.57K | 32.15K | 26.31K | 1.9K | |
| Market cap | 568.51B | 603.67B | 422.57B | 398.42B | 5842.87B | |
| Enterprise value | 612.76B | 775.16B | 666.56B | 580.02B | 5970B | |
| P/E ratio | 18.91 | 17.62 | 28.58 | 17.67 | 105.31 | |
| Price to sales ratio | 3.77 | 3.24 | 1.67 | 1.73 | 20.04 | |
| POCF ratio | 26.25 | -1.05K | -36.3 | 5.26 | 78.84 | |
| PFCF ratio | -11.07 | -5.52 | -6.59 | 5.98 | 129.64 | |
| P/B Ratio | 3.51 | 3.11 | 2.04 | 1.74 | 20.02 | |
| PTB ratio | 3.51 | 3.11 | 2.04 | 1.74 | 20.02 | |
| EV to sales | 4.07 | 4.16 | 2.64 | 2.52 | 20.48 | |
| Enterprise value over EBITDA | 14.95 | 16.02 | 12.53 | 11.79 | 63.52 | |
| EV to operating cash flow | 28.29 | -1.35K | -57.25 | 7.66 | 80.55 | |
| EV to free cash flow | -11.93 | -7.08 | -10.4 | 8.7 | 132.46 | |
| Earnings yield | 0.05 | 0.06 | 0.03 | 0.06 | 0.01 | |
| Free cash flow yield | -0.09 | -0.18 | -0.15 | 0.17 | 0.01 | |
| Debt to equity | 0.31 | 0.51 | 0.78 | 0.37 | 0.33 | |
| Debt to assets | 0.48 | 0.55 | 0.62 | 0.55 | 0.49 | |
| Net debt to EBITDA | 1.08 | 3.55 | 4.59 | 3.69 | 1.35 | |
| Current ratio | 1.54 | 1.21 | 1.29 | 1.01 | 1.33 | |
| Interest coverage | 96.99 | 30.43 | 8.66 | 4.93 | 11.5 | |
| Income quality | 0.72 | -0.02 | -0.79 | 3.36 | 1.34 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.02 | 0.04 | 0.09 | 0 | 0.03 | |
| Sales general and administrative to revenue | 0.05 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Research and developement to revenue | 0.03 | 0.05 | 0.03 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
| Capex to operating cash flow | -3.37 | 189.41 | 4.5 | -0.12 | -0.39 | |
| Capex to revenue | -0.48 | -0.58 | -0.21 | -0.04 | -0.1 | |
| Capex to depreciation | -14.93 | -21.81 | -3.92 | -0.61 | -2.2 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 40.57K | 44.85K | 30.42K | 39.55K | 5.75K | |
| ROIC | 0.19 | 0.14 | 0.12 | 0.12 | 0.18 | |
| Return on tangible assets | 0.1 | 0.08 | 0.03 | 0.04 | 0.1 | |
| Graham Net | -9.26K | -22.66K | -32.28K | -25.09K | -1.67K | |
| Working capital | 52.05B | 29.51B | 51.06B | 1.99B | 60.06B | |
| Tangible asset value | 160.64B | 192.33B | 204.21B | 226.47B | 288.88B | |
| Net current asset value | 757.47M | -72.2B | -114.8B | -86.36B | -38.82B | |
| Invested capital | 0.6 | 1 | 1.31 | 0.95 | 0.66 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 7.02B | 8.17B | 10.4B | 8.28B | 9.13B | |
| Average inventory | 45.26B | 51B | 61.18B | 55.61B | 65.86B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 47.73 | 52.93 | 53.74 | 34.76 | 37.01 | |
| Days of inventory on hand | 289.38 | 304.87 | 286.58 | 233.43 | 282.42 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 7.65 | 6.9 | 6.79 | 10.5 | 9.86 | |
| Inventory turnover | 1.26 | 1.2 | 1.27 | 1.56 | 1.29 | |
| ROE | 0.19 | 0.18 | 0.07 | 0.1 | 0.19 | |
| Capex per share | -8.95K | -12.62K | -6.08K | -1.05K | -276.86 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 8.25K | 1.17K | 925.67 | 11.21K | 10.51K | |
| Net income per share | 1.63K | 230.12 | 194.74 | 4.19K | 2.85K | |
| Operating cash flow per share | 1.42K | 388.1 | 57.96 | 1.41K | 3.25K | |
| Free cash flow per share | 566.81 | 442.12 | -41.13 | -1.4K | 2.66K | |
| Cash per share | 7.77K | 817.77 | 807.53 | 8.15K | 0 | |
| Book value per share | 31.49K | 3.62K | 3.82K | 40.11K | 44K | |
| Tangible book value per share | 31.15K | 3.59K | 3.78K | 39.73K | 43.91K | |
| Share holders equity per share | 31.49K | 3.62K | 3.82K | 40.11K | 44K | |
| Interest debt per share | 25.48K | 2.42K | 2.37K | 24.01K | 534.8 | |
| Market cap | 659.73B | 5619.8B | 5796.93B | 738.15B | 720.04B | |
| Enterprise value | 815.95B | 5746.92B | 5921.22B | 873.34B | 720.04B | |
| P/E ratio | 11.73 | 75.83 | 92.43 | 5.11 | 7.34 | |
| Price to sales ratio | 9.27 | 59.74 | 77.78 | 7.64 | 7.94 | |
| POCF ratio | 54.05 | 179.85 | 1.24K | 60.87 | 25.72 | |
| PFCF ratio | 134.97 | 157.87 | -1.75K | -60.99 | 31.35 | |
| P/B Ratio | 2.43 | 19.26 | 18.86 | 2.13 | 1.9 | |
| PTB ratio | 2.43 | 19.26 | 18.86 | 2.13 | 1.9 | |
| EV to sales | 11.46 | 61.09 | 79.45 | 9.03 | 7.94 | |
| Enterprise value over EBITDA | 36.17 | 180.12 | 214.12 | 18.42 | 17.14 | |
| EV to operating cash flow | 66.85 | 183.92 | 1.27K | 72.01 | 25.72 | |
| EV to free cash flow | 166.92 | 161.45 | -1.79K | -72.16 | 31.35 | |
| Earnings yield | 0.02 | 0 | 0 | 0.05 | 0.03 | |
| Free cash flow yield | 0.01 | 0.01 | 0 | -0.02 | 0.03 | |
| Debt to equity | 0.31 | 0.33 | 0.29 | 0.27 | 0 | |
| Debt to assets | 0.52 | 0.49 | 0.47 | 0.45 | 0.44 | |
| Net debt to EBITDA | 6.92 | 3.98 | 4.49 | 2.85 | 0 | |
| Current ratio | 1.16 | 1.33 | 1.39 | 1.49 | 1.57 | |
| Interest coverage | 9.6 | 18.34 | 14.23 | 21.86 | 7.31 | |
| Income quality | 0.87 | 1.69 | 0.3 | 0.34 | 1.14 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.05 | 0.04 | 0.04 | 0.03 | 0.3 | |
| Research and developement to revenue | 0.02 | 0.01 | 0.02 | 0.01 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.6 | 0 | -1.71 | -2 | -0.18 | |
| Capex to revenue | -0.1 | 0 | -0.11 | -0.25 | -0.06 | |
| Capex to depreciation | -2.87 | 0 | -1.81 | -5.01 | -1.11 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 33.99K | 4.33K | 4.09K | 61.5K | 53.07K | |
| ROIC | 0.04 | 0.07 | 0.05 | 0.08 | 0.07 | |
| Return on tangible assets | 0.02 | 0.03 | 0.03 | 0.06 | 0.04 | |
| Graham Net | -22.06K | -2.18K | -2.04K | -20.13K | -34.5K | |
| Working capital | 32.17B | 60.06B | 68.94B | 92.4B | 116.58B | |
| Tangible asset value | 268.59B | 288.88B | 304.28B | 342.62B | 0 | |
| Net current asset value | -57.03B | -38.82B | -23.61B | -3.88B | 24.58B | |
| Invested capital | 0.8 | 0.66 | 0.62 | 0.59 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 9.2B | 9.37B | 8.1B | 8.76B | 0 | |
| Average inventory | 80.44B | 79.43B | 81.93B | 82.75B | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 34.97 | 30.71 | 30.72 | 27.24 | 0 | |
| Days of inventory on hand | 283.43 | 234.29 | 335.15 | 257.32 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.57 | 2.93 | 2.93 | 3.3 | 0 | |
| Inventory turnover | 0.32 | 0.38 | 0.27 | 0.35 | 0 | |
| ROE | 0.05 | 0.06 | 0.05 | 0.1 | 0.06 | |
| Capex per share | -848.42 | 0 | -99.08 | -2.81K | -582.92 |
145720.KS Frequently Asked Questions
What is Dentium CO., LTD stock symbol ?
Dentium CO., LTD is a US stock and trading under the symbol 145720.KS
What is Dentium CO., LTD stock quote today ?
Dentium CO., LTD stock price is $88900 today.
Is Dentium CO., LTD stock public?
Yes, Dentium CO., LTD is a publicly traded company.
Company Profile
- Volume Average 86.01K
- Market Capitalization 766.66B
- Employee 672
- Headquarters Seoul,US
- IPO Date 2017-03-16
-
Website
https://www.dentium.com 
Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.
